Skip to main content
SpringerLink
Log in

Chronisch entzündliche Darmerkrankungen

  • Chapter
Klinische Gastroenterologie und Stoffwechsel

  • 163 Accesses

Zusammenfassung

Morbus Crohn und Colitis ulcerosa sind chronisch entzündliche Darmerkrankungen, deren Ätiologie nicht geklärt ist. Sie sind überwiegend im Kolon lokalisiert und manifestieren sich durch Diarrhöen, die häufig blutig sind. Zahlreiche extraintestinale Manifestationen können vor oder zusammen mit dem Auftreten intestinaler Symptome das klinische Bild prägen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adler G (1996) Morbus Crohn — Colitis ulcerosa, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  • Baert FJ, D’Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ (1999) Tumor necrosis factor a antibody (Infliximab) therapy profoundly down-regulates the inflammation in Crohn’s ileocolitis. Gastroenterology 116: 22–28

    Article  PubMed  CAS  Google Scholar 

  • Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, Reshef R, Odes S, Moshkovitz M, Brück R, Eliakim R, Maoz E, Mittmann U (1998) Budesonide versus prednisone in the treatment of active Crohn’s disease. Gastroenterology 115: 835–840

    Article  PubMed  CAS  Google Scholar 

  • Bayless TM, Tokayer AZ, Polito JM, Quaskey SA, Mellits ED, Harris ML (1996) Crohns disease: concordance for site and clinical type in affected family members: potential hereditary influences. Gastroenterology 111: 573–579

    Article  PubMed  CAS  Google Scholar 

  • Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 334: 1557–1560

    Article  PubMed  CAS  Google Scholar 

  • Best WR, Becktel JM, Singleton JW et al. (1976) Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 70: 439–444

    PubMed  CAS  Google Scholar 

  • Binder V, Hendriksen C, Kreiner S (1985) Prognosis in Crohn’s disease — based on results from a regional patient group from the county of Copenhagen. Gut 26: 146–150

    Article  PubMed  CAS  Google Scholar 

  • Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G (1997) Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 92: 1157–1163

    PubMed  CAS  Google Scholar 

  • Bouhnik Y, Lemann M, Mary JY, Scemama G, Tai R, Matuchansky C, Modigliani R, Rambaud JC (1996) Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercaptopurine. Lancet 347: 215–219

    Article  PubMed  CAS  Google Scholar 

  • Brambs H-J, Adler G (1995) Bildgebende Verfahren in der Diagnostik chronisch entzündlicher Darmerkrankungen. Bildgebung 62: 81–92

    PubMed  CAS  Google Scholar 

  • Brandtzaeg P, Halstensen TS, Helgeland L et al. (1992) The mucosal immune system in inflammatory bowel disease. In: MacDonald TT (ed) Immunology of gastrointestinal disease. Kluwer Academic Publishers, Boston London, pp 19–40

    Chapter  Google Scholar 

  • Brignola C, Cottone M, Pera A et al. (1995) Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn’s disease. Gastroenterology 108: 345–349

    Article  PubMed  CAS  Google Scholar 

  • Buckley M, O’Morain C (1994) Salicylates, steroids and immunosuppres-sants in Crohn’s disease. Eur J Gastroenterol Hepatol 6: 85–92

    Google Scholar 

  • Campieri M, De Franchis R, Bianchi Porro G et al. (1990) Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. Scand J Gastroenterol 25: 663–668

    Article  PubMed  CAS  Google Scholar 

  • Cellier C, Sahmoud T, Froguel E et al. (1994) Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. Gut 35: 231–235

    Article  PubMed  CAS  Google Scholar 

  • Cohen RD, Hanauer SB (1995) Surveillance colonoscopy in ulcerative colitis: is the message loud and clear? Am J Gastroenterol 90: 2090–2092

    PubMed  CAS  Google Scholar 

  • Collins CE, Rampton DS (1995) Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 36: 5–8

    Article  PubMed  CAS  Google Scholar 

  • Collins CE, Cahill MR, Newland AC et al. (1994) Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106: 840–845

    PubMed  CAS  Google Scholar 

  • Colombel JF, Grandbastien B, Gower Rousseau C et al. (1996) Clincal characteristics of Crohns disease in 72 families. Gastroenterology. 111: 604–607

    Article  PubMed  CAS  Google Scholar 

  • Connell WR, Kamm MA, Dickson M et al. (1994) Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343: 1249–1252

    Article  PubMed  CAS  Google Scholar 

  • Cottone M, Rosselli M, Orlando A et al. (1994) Smoking habits and recurrence in Crohn’s disease. Gastroenterology 106: 643–648

    PubMed  CAS  Google Scholar 

  • Couckuyt H, Gevers AM, Coremans G, Hiele M, Rutgeerts P (1995) Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut 36: 577–580

    Article  PubMed  CAS  Google Scholar 

  • Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Stokkers P, van Deventer SH, Mirza M, Raedler A, Kruis W, Meckler U, Theuer D, Herrmann T, Gionchetti P, Lee J, Mathew C, Lennard Jones J (1998) Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 115: 1066–1071

    Article  PubMed  CAS  Google Scholar 

  • Debinski HS, Kamm MA (1995) Novel drug therapies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7: 169–182

    PubMed  CAS  Google Scholar 

  • D’Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P (1997) Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn’s disease. Gastroenterology 112: 1475–1481

    Article  PubMed  Google Scholar 

  • D’Haens G, Rutgeers P, Geboes K et al. (1994) The natural history of esophageal Crohn’s disease: three patterns of evolution. Gastrointest Endosc 40: 296–300

    Article  PubMed  Google Scholar 

  • Duerr RH (1996) Genetics of inflammatory bowel disease. Infl Bow Dis 2: 48–60

    Article  Google Scholar 

  • Egan LJ, Sandborn WJ, Tremaine WJ (1998) Clinical outcome following treatment of refractory inflammatory and flstulizing Crohn’s disease with intravenous cyclosporine. Am J Gastroenterol 93: 442–448

    Article  PubMed  CAS  Google Scholar 

  • Ekbom A, Helmick C, Zack M et al. (1991) Ulcerative proctitis in Central Sweden 1965–1983. Dig Dis Sci 36: 97–102

    Article  PubMed  CAS  Google Scholar 

  • Ekbom A, Helmick CG, Zack M et al. (1992) Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 103: 954–960

    PubMed  CAS  Google Scholar 

  • El Mouaaouy A, Tolksdorf A, Starlinger M et al. (1992) Endoskopische Sonographie des Anorektums bei entzündlichen Enddarmerkrankungen. Z Gastroenterol 30: 486–494

    PubMed  CAS  Google Scholar 

  • Farmer RG, Hawk WA, Turnbull Jr RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68: 627–635

    PubMed  CAS  Google Scholar 

  • Farmer RG, Easley KA, Rankin GB (1993) Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1.116 patients. Dig Dis Sci 38: 1137–1146

    Article  PubMed  CAS  Google Scholar 

  • Feagan BG, Rochon J, Fedorak RN et al. (1995) Methotrexate for the treatment of Crohn’s disease. N Engl J Med 332: 292–297

    Article  PubMed  CAS  Google Scholar 

  • Fellermann K, Ludwig D, Stahl M, Walek TD, Stange ER 1998. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Am J Gastroenterol 93: 1860–1866

    Article  PubMed  CAS  Google Scholar 

  • Fischbach W, Becker W (Hrsg) (1993) Diagnostik chronischentzündlicher Darmerkrankungen. Thieme, Stuttgart New York

    Google Scholar 

  • Gaffney PR, Doyle CT, Gaffney A et al. (1995) Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 90: 220–223

    PubMed  CAS  Google Scholar 

  • Gaginella TS, Walsh RE (1992) Sulfasalazine — multiplicity of action. Dig Dis Sci 37: 801–812

    Article  PubMed  CAS  Google Scholar 

  • Garau P, Orenstein SR, Neigut A et al. (1994) Pancreatitis associated with Olsalazine and Sulfalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 18: 481–485

    Article  PubMed  CAS  Google Scholar 

  • Giocchetti P, Schiavina M, Campieri M et al. (1990) Bronchopulmonary involvement in ulcerative colitis. J Clin Gastroenterol 12: 647–650

    Article  Google Scholar 

  • Godet PG, May GR, Sutherland LR (1995) Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 37: 668–673

    Article  PubMed  CAS  Google Scholar 

  • Goebell H (1988) Different activity indices in Crohn’s disease and their possible role. In: Goebell H, Peskar B, Malchow H (eds) Inflammatory bowel diseases. Basic research and clinical implications. MTP, Lancaster, pp 253–258

    Google Scholar 

  • Goebell H, Förster S, Dirks E et al. (1987) Morbus Crohn: Klinische Erkrankungsmuster in Beziehung zur Lokalisation. Med Klin 82: 1–8

    CAS  Google Scholar 

  • Greenberg GR, Feagan BG, Martin F et al. (1994) Oral budesonide for active Crohn’s disease. N Engl J Med 331: 836–841

    Article  PubMed  CAS  Google Scholar 

  • Griffiths AM, Ohlsson A, Sherman PM et al. (1995) Meta-analysis of enterai nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 108: 1056–1067

    Article  PubMed  CAS  Google Scholar 

  • Gross V, Andus T, Fischbach W et al. (1995) Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn’s ileocolitis. A multicenter randomized double-blind study. Z Gastroenterol 33: 581–584

    PubMed  CAS  Google Scholar 

  • Hagett PJ, Moore NR, Shearman JD et al. (1995) Pelvic and perineal complications of Crohn’s disease: assessment using magnetic resonance imaging. Gut 36: 407–410

    Article  Google Scholar 

  • Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, Walton-Bowen K, Haskell L, Levine JG (1998) Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. Gastroenterology 115: 525–532

    Article  PubMed  CAS  Google Scholar 

  • Hanauer S, Schwartz J, Robinson M et al. (1993) Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Am J Gastroenterol 88: 1188–1197

    PubMed  CAS  Google Scholar 

  • Hawthorne AB, Daneshmend TK, Hawkey CJ et al. (1992) Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33: 922–928

    Article  PubMed  CAS  Google Scholar 

  • Hellers G, Cortot A, Jewell D, Leijonmarck CE, Löfberg R, Malchow H, Nilsson LG, Pallone F, Pena S, Persson T, Prantera C, Rutgeerts P (1999) Oral budesonide for prevention of postsurgical recurrence in Crohn’s disease. Gastroenterology 116: 294–300

    Article  PubMed  CAS  Google Scholar 

  • Herbay A von, Otto HF (1992) Differentialdiagnostik chronisch-entzündlicher Darmerkrankungen. Möglichkeiten und Grenzen der Morphologie. Chirurg 63: 1–7

    Google Scholar 

  • Herbay A von, Herfarth Ch, Otto HF (1994) Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol 32: 382–388

    Google Scholar 

  • Herbay A von, Heuschen U, Herfarth Ch (1996) Backwash ileitis is common in ulcerative colitis and covers the full spectrum of UC lesions and complications. In: Tytgat G (ed) Inflammatory bowel disease. Kluwer, Dordrecht Boston London

    Google Scholar 

  • Herbay A von, Schmid RM, Adler G (1999) Kolorektale Karzinome bei Morbus Crohn. Dtsch Med Wochenschr 124: 940–944

    Article  Google Scholar 

  • Herfarth C, Stern J (1991) Ileum-Pouch: Indikationen, Techniken, Langzeitergebnisse. Dtsch Med Wochenschr 116: 1485–1490

    Article  PubMed  CAS  Google Scholar 

  • Hodgson HJF, Bhatti M (1995) Assessment of disease activity in ulcerative colitis and Crohn’s disease. Infl Bow Dis 1: 117–134

    Article  Google Scholar 

  • Hugot JP, Laurent Puig P, Gower Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti Pellie C, Weissenbach J, Mathew CG, Lennard Jones JE, Cortot A, Colombel JF, Thomas G (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379: 821–823

    Article  PubMed  CAS  Google Scholar 

  • Kayser K, Probst F, Gabius HJ et al. (1990) Are there characteristic alterations of lung tissue associated with Crohn’s disease? Path Res Pract 186: 485–490

    Article  PubMed  CAS  Google Scholar 

  • Kirsner JB (1995) The historical basis of the idiopathic inflammatory bowel diseases. Infl Bow Dis 1: 2–26

    Article  Google Scholar 

  • Kruis W, Judmaier G, Kayasseh L et al. (1995) Double-blind dose-finding study of olsalazine versus sulphalazine as maintenance therapy for ulcerative colitis. Eur J Gastroenterol Hepatol 7: 391–396

    PubMed  CAS  Google Scholar 

  • Küchenhoff J, Manz R, Mathes L (1995) Was beeinflußt den Krankheitsverlauf des Morbus Crohn? Nervenarzt 66: 41–48

    PubMed  Google Scholar 

  • Langholz E, Munkholm P, Davidsen M et al. (1992) Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103: 1444–1451

    PubMed  CAS  Google Scholar 

  • Langholz E, Munkholm P, Davidsen M (1994) Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 107: 3–11

    PubMed  CAS  Google Scholar 

  • Lebwohl M, Lebwohl O (1998) Cutaneous manifestations of inflammatory bowel disease. Inflamm Bow Dis 4: 142–148

    Article  CAS  Google Scholar 

  • Lee Y-M, Kaplan MM (1995) Primary sclerosing cholangitis. Semin Liver Dis 11: 11–17

    Google Scholar 

  • Lennard-Jones JE (1995) Surveillance in ulcerative colitis: Is it worthwhile? Does it save lives? Infl Bow Dis 1: 76–79

    Article  Google Scholar 

  • Lochs H, Steinhardt HJ, Klaus-Wentz B et al. (1991) Comparison of enterai nutrition and drug treatment in active Crohn’s disease. Gastroenterology 101: 881–888

    PubMed  CAS  Google Scholar 

  • Löfberg R (1995) New steroids for inflammatory bowel disease. Infl Bow Dis 1: 135–141

    Article  Google Scholar 

  • Löfberg R, Danielsson Å, Suhr O, Nilsson Å, Schiöler R, Nyberg A, Hultcrantz R, Kollberg B, Gillberg R, Willén R, Persson T, Salde L (1996) Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology 110: 1713–1718

    Article  PubMed  Google Scholar 

  • Lunniss PJ, Philips RKS (1994) Extra-intestinal fistulae and perianal disease in Crohn’s disease. Eur J Gastroenterol 6: 100–107

    Article  Google Scholar 

  • Malchow H, Ewe K, Brandes JW et al. (1984) European cooperative Crohn’s disease study (ECCDS): Results of drug treatment. Gastroenterology 86: 249–266

    PubMed  CAS  Google Scholar 

  • Marshall JK, Irvine EJ (1997) Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 40: 775–781

    Article  PubMed  CAS  Google Scholar 

  • Martini GA (1991) Zur Geschichte der chronisch-entzündlichen Darmerkrankungen (Colitis ulcerosa und Morbus Crohn). Internist 32: 505–510

    PubMed  CAS  Google Scholar 

  • Meuwissen SGM, Crusius JBA, Pena AS et al. (1997) Spondyloarthropathy and idiopathic inflammatory bowel diseases. Infl Bow Dis 3: 25–37

    Article  Google Scholar 

  • Michelassi F, Stella M, Balestracci T et al. (1993) Incidence, diagnosis and treatment of enteric and colorectal fistulae in patients with Crohn’s disease. Ann Surg 218: 660–666

    Article  PubMed  CAS  Google Scholar 

  • Miner P, Hanauer S, Robinson M et al. (1995) Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 40: 296–304

    Article  PubMed  CAS  Google Scholar 

  • Modigliani R, Mary JY, Simon JF et al. (1990) Clinical, biological and endoscopic picture of attacks of Crohn’s disease. Gastroenterology 98: 811–818

    Article  PubMed  CAS  Google Scholar 

  • Monsén U, Sorstad J, Hellers G et al. (1991) Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol 85: 711–716

    Google Scholar 

  • Montgomery SM, Morris DL, Pounder RE, Wakefield AJ (1999) Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 116: 796–803

    Article  PubMed  CAS  Google Scholar 

  • Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Büschenfelde KH, Schlaak JF (1999) Randomized trial of mycofenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease. Gut 44: 625–628

    Article  PubMed  CAS  Google Scholar 

  • Novacek G, Kleinberger M, Vogelsang H et al. (1995) Budesonide in glucocorticoid dependent chronic active Crohn’s disease; a pilot study. Z Gastroenterol 33: 251–254

    PubMed  CAS  Google Scholar 

  • Orholm M, Munkholm P, Langholz E et al. (1991) Familial occurrence of inflammatory bowel disease. N Engl J Med 324: 84–88

    Article  PubMed  CAS  Google Scholar 

  • Pearson DC, May GR, Fick GH et al. (1995) Azathioprine and 6-Mercaptopurine in Crohn disease. Ann Intern Med 122: 132–142

    Google Scholar 

  • Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tabacco smoke — a case-control study. Gut 31: 1377–1381

    Article  PubMed  CAS  Google Scholar 

  • Present DH (1993) Toxic megacolon. Med Clin North Am 77: 1129–1148

    PubMed  CAS  Google Scholar 

  • Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hoegenzand RA, Podolsky DK, Sands BE, Braakman T, De Woody KL, Schaible TF, van Deventer SJH (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340: 1398–1404

    Article  PubMed  CAS  Google Scholar 

  • Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 298: 82–86

    Article  CAS  Google Scholar 

  • Reimann J, Rudolphi A, Claesson MH (1995) Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Mol Med 73: 133–140

    Article  PubMed  CAS  Google Scholar 

  • Reinshagen M, Loeliger C, Kuehnl P et al. (1996) HLA class II gene frequencies in Crohn’s disease: a population based analysis in Germany. Gut 38: 538–542

    Article  PubMed  CAS  Google Scholar 

  • Rieber A, Wruk D, Nüssle K, Aschoff AJ, Reinshagen M, Adler G, Brambs HJ, Tomczak R (1998) MRT des Abdomens in Kombination mit der Enteroklyse bei Morbus Crohn unter Verwendung von oralem und intravenösen Gd-DTPA. Radiologe 38: 23–28

    Article  PubMed  CAS  Google Scholar 

  • Riordan AM, Hunter JO, Cowan RE et al. (1993) Treatment of active Crohn’s disease by exclusion diet: east anglian multi-centre controlled trial. Lancet 342: 1131–1134

    Article  PubMed  CAS  Google Scholar 

  • Roberts WG, Simon TJ, Berlin RG et al. (1997) Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 112: 725–732

    Article  PubMed  CAS  Google Scholar 

  • Rosen CB, Nagorney DM (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 11: 26

    Article  PubMed  CAS  Google Scholar 

  • Rowbotham DS, Mapstone NP, Trejdosiewicz LK et al. (1995) Mycobacterium paratuberculosis DNA not detected in Crohn’s disease tissue by fluorescent polymerase chain reaction. Gut 37: 660–667

    Article  PubMed  CAS  Google Scholar 

  • Rüssel MG, Dorant E, Brummer RJM, van de Kruis MA, Muris JW, Bergers JM, Goedhard J, Stockbrügger RW (1997) Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: results of a large case-control study. Gastroenterology 113: 377–382

    Article  PubMed  Google Scholar 

  • Rutgeerts P, D’Haens G, Hiele M, Geboes K, Vantrappen G (1994) Appendectomy protects against ulcerative colitis. Gastroenterology 106: 1251–1253

    PubMed  CAS  Google Scholar 

  • Rutgeerts P, Hiele M, Geboes K et al. (1996) Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 108: 1617–1621

    Article  Google Scholar 

  • Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14: 199–202

    Article  PubMed  CAS  Google Scholar 

  • Sandborn WJ (1995) A critical review of cyclosporine therapy in inflammatory bowel disease. Infl Bow Dis 1: 48–63

    Article  Google Scholar 

  • Scheppach W, Christi SU, Bartram HP, Richter F, Kasper H (1997) Effects of short-chain fatty acids on the inflamed colonic mucosa. Scand J Gastroenterol 32 (Suppl 222): 53–57

    CAS  Google Scholar 

  • Schreiber S, Hamling J, Zehnter E, Howaldt S, Daerr W, Raedler A, Kruis W (1997) Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate. Gut 40: 761–766

    Article  PubMed  CAS  Google Scholar 

  • Schwerk WB, Beckh K, Raith M (1992) A prospective study of high resolution sonography in the diagnosis of inflammatory bowel disease. Eur J Gastroenterol Hepatol 4: 173–182

    Google Scholar 

  • Scully RE (ed) (1994) Case records of the Massachusetts General Hospital. Weekly clinicopathologic exercises. Case 3-1994. N Engl J Med 330: 96–202

    Google Scholar 

  • Shivananda S, Lennard Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39: 690–697

    Article  PubMed  CAS  Google Scholar 

  • Singleton JW, Hanauer SB, Gitnick GL et al. (1993) Mesalamine capsules for the treatment of active Crohn’s disease: results of a 16-week trial. Gastroenterology 104: 1293–1301

    PubMed  CAS  Google Scholar 

  • Skalej M, Makowiec F, Weinlich M et al. (1993) Kernspintomographie bei perianalem Morbus Crohn. Dtsch Med Wochenschr 118: 1791–1796

    Article  PubMed  CAS  Google Scholar 

  • Smedh K, Olaison G, Jönsson KÅ et al. (1995) Interobserver variation of colonoileoscopic findings in Crohn’s disease. Scand J Gastroenterol 30: 81–86

    Article  PubMed  CAS  Google Scholar 

  • Soukiasian SH, Foster CS, Raizman MB (1994) Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophtalmol 118: 601–611

    CAS  Google Scholar 

  • Spencer CM, McTavish D (1995) Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs 50: 854–872

    Article  PubMed  CAS  Google Scholar 

  • Stack WA, Mann SD, Roy AJ et al. (1997) Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohns disease. Lancet 349: 521–524

    Article  PubMed  CAS  Google Scholar 

  • Stange EF, Modigliani R, Salvador Pena A et al. (1995) European trial of cyclosporine in chronic active Crohn’s disease: a 12-month study. Gastroenterology 109: 774–782

    Article  PubMed  CAS  Google Scholar 

  • Stange EF, Schreiber S, Raedler A, Stallmach A, Schölmerich J, Loeschke K, Starlinger M, Fischbach W, Caspary WF (1997) Therapie des Morbus Crohn — Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 35: 541–554

    PubMed  CAS  Google Scholar 

  • Steinhardt HJ, Loeschke K, Kasper H et al. (1985) European Cooperative Crohn’s Disease Study (ECDS): Clinical features and natural history. Digestion 31: 97–108

    Article  PubMed  CAS  Google Scholar 

  • Steinhart AH, McLeod RS (1996) Medical and surgical management of perianal Crohn’s Disease. Infl Bow Dis 2: 200–210

    Article  Google Scholar 

  • Summers RW, Switz DM, Sessions JT Jr et al. (1979) National cooperative Crohn’s disease study: Results of drug treatment. Gastroenterology 77: 847–869

    PubMed  CAS  Google Scholar 

  • Sutherland LR, Martin F, Gréer S et al. (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitisproctosigmoidtitis, and proctitis. Gastroenterology 92: 1894–1898

    PubMed  CAS  Google Scholar 

  • Sutherland L, Singleton J, Sessions J et al. (1991) Double blind, placebo controlled trial of metronidazole in Crohn’s disease. Gut 32: 1071–1075

    Article  PubMed  CAS  Google Scholar 

  • Talbot RW, Heppell J, Dozois RR et al. (1986) Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61: 140–145

    PubMed  CAS  Google Scholar 

  • Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med 337: 1029–1035

    Article  PubMed  CAS  Google Scholar 

  • Thomas GAO, Rhodes J, Mani V et al. (1995) Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 332: 988–992

    Article  PubMed  CAS  Google Scholar 

  • Thomsen Oø, Cortot A, Jewell D, Wright JP, Winter T, Tavarela Veloso F, Vatin M, Persson T, Pettersson E (1998) A comparison of budesonide and mesalamine for active Crohn’s disease. N Engl J Med 339: 370–374

    Article  PubMed  CAS  Google Scholar 

  • Tirpitz C von, Pischulti G, Claus J, Rieber A, Brückel J, Boehm BO, Adler G, Reinshagen M (1999) Pathologische Knochendichte bei chronisch entzündlichen Darmerkrankungen. Z Gastroenterol 37: 1021–1028

    Google Scholar 

  • Toyoda H, Wang SJ, Yang H et al. (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104: 741–748

    PubMed  CAS  Google Scholar 

  • Tromm A, Möllmann HW, May B (1996) Praxis der Glukokortikoidtherapie chronisch entzündlicher Darmerkrankungen. In: May B, Möllmann HW (Hrsg) Glukokortikoidtherapie chronisch entzündlicher Darmerkrankungen. Falk Foundation, Freiburg, S 9–26

    Google Scholar 

  • Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2: 1041–1048

    Article  PubMed  CAS  Google Scholar 

  • Van Hees PAM, Van Eiteren PH, Van Lier HJJ et al. (1980) An index of inflammatory activity in patients with Crohn’s disease. Gut 21: 279–286

    Article  PubMed  Google Scholar 

  • Wakefield AJ, Ekbom A, Dhillon AP et al. (1995) Crohn’s disease: Pathogenesis and persistent measles virus infection. Gastroenterology 108: 911–916

    Article  PubMed  CAS  Google Scholar 

  • Wilcox GM, Aretz HT, Roy MA et al. (1990) Glomerulonephritis associated with inflammatory bowel disease. Gastroenterology 98: 786–791

    PubMed  CAS  Google Scholar 

  • Wu S, Craig RM (1995) Intense nutritional support in inflammatory bowel disease. Dig Dis Sci 40: 843–852

    Article  PubMed  CAS  Google Scholar 

  • Yang H, Vora DK, Targan SR et al. (1995) Intracellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 109: 440–448

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Reinshagen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. Innere Medizin I, Universitätsklinik Ulm, 89070, Ulm, Germany

    G. Adler

  2. Departement Innere Medizin Abt. Gastroenterologie Kantonsspital Basel, Universitätskliniken, Petersgraben 4, 4031, Basel, Schweiz

    C. Beglinger

  3. Abt. Gastroenterologie und Hepatologie Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    M. P. Manns

  4. Abt. für Innere Medizin, Park-Klinik Weißensee, Schönstraße 80, 13086, Berlin, Germany

    S. Müller-Lissner

  5. Medizinische Universitätsklinik Knappschaftskrankenhaus, In der Schornau 23-25, 44892, Bochum, Germany

    W. Schmiegel

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adler, G., Reinshagen, M. (2000). Chronisch entzündliche Darmerkrankungen. In: Adler, G., Beglinger, C., Manns, M.P., Müller-Lissner, S., Schmiegel, W. (eds) Klinische Gastroenterologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57194-7_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57194-7_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65059-1

  • Online ISBN: 978-3-642-57194-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation